Eagle attended the 2023 PDA Pharmaceutical Microbiology Conference taking place this October 2nd – 4th in Washington DC.
The conference addressed the most relevant opportunities and challenges to the future of microbiology in our global market. Professionals from all facets of the global industry, academia, and regulatory authorities, shared insights on how to best prepare for the future through best practices, development of standards, and integration of innovative technologies.
The event proved to be of great value and we look forward to participating in next year’s conference.
Eagle is a U.S. Food and Drug Administration (FDA) and Drug Enforcement Agency (DEA) registered A2LA ISO 17025 accredited laboratory founded in 2003 that provides analytical chemistry and microbiological testing, consultation services, and other technical services for pharmacies, highly regulated industries, and research organizations to support their compliance needs.
Latest posts by Eagle Analytical (see all)
- Eagle New Year Party & Eagle Employee Of The Year Award Ceremony, 01/13 - March 11, 2024
- HRT Functional Medicine Symposium, 02/15 – 02/17 - March 11, 2024
- APhA, 03/22 – 03/25 - March 11, 2024
